Show items per page
Elements: 120
Page 1 on 3
 TitleAuthors / EditorsDate
add to browser selection
A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism De Moerloose, Philippe; Palareti, Gualtiero; Aguilar, Carlos; Legnani, Cristina; ... Peetz, Dirk 2008
add to browser selection
A multicenter study to assess the reproducibility of antiphospholipid antibody results produced by an automated system Devreese, K M; Poncet, Antoine; Lindhoff-Last, E; Musial, J; ... Fontana, Pierre 2017
add to browser selection
A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis Robert-Ebadi, Helia; Le Querrec, Agnès; De Moerloose, Philippe; Gandon-Laloum, Sylvie; ... Neerman Arbez, Marguerite 2008
add to browser selection
A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family Levrat, Emmanuel; Aboukhamis, Imad; De Moerloose, Philippe; Farho, Jaafar; ... Neerman Arbez, Marguerite 2011
add to browser selection
A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream Robert-Ebadi, Helia; De Moerloose, Philippe; El Khorassani, M.; El Khattab, M.; Neerman Arbez, Marguerite 2009
add to browser selection
A survey of adherence to haemophilia therapy in six European countries: results and recommendations De Moerloose, Philippe; Urbancik, W.; Van Den Berg, H M.; Richards, M. 2008
add to browser selection
Acquired factor XIII deficiency: a therapeutic challenge Boehlen, Françoise; Casini, Alessandro; Chizzolini, Carlo; Mansouri, Behrouz; ... De Moerloose, Philippe 2013
add to browser selection
Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G→T Attanasio, Catia; De Moerloose, Philippe; Antonarakis, Stylianos; Morris, Michael Andréw; Neerman Arbez, Marguerite 2001
add to browser selection
Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation Beghetti, Maurice; Reber, Guido; De Moerloose, Philippe; Vadas, Laszlo; ... Rimensberger, Peter 2002
add to browser selection
Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome De Moerloose, Philippe; Reber, Guido; Musial, J.; Arnout, J. 2010
add to browser selection
Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex Pagano, Sabrina; Satta, Nathalie; Werling, D; Offord, Valérie Edna; ... Vuilleumier, Nicolas 2012
add to browser selection
Anti-beta(2)-glycoprotein I ELISA assay: the influence of different antigen preparations Cavazzana, Anna; Pengo, Vittorio; Tonello, Marta; Noventa, Franco; ... Ruffatti, A. 2009
add to browser selection
Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation Regnault, V; Boehlen, Françoise; Ozsahin, Ayse Hulya; Wahl, Denys; ... De Moerloose, Philippe 2005
add to browser selection
Anticoagulants in portal vein thrombosis: don't be so shy! Spahr, Laurent François Joséph; Boehlen, Françoise; De Moerloose, Philippe; Hadengue, Antoine 2009
add to browser selection
Anticoagulation orale et pharmacogénétique : perspectives pour la pratique clinique Benusiglio, Patrick Raphaël; Desmeules, Jules Alexandre; De Moerloose, Philippe; Dayer, Pierre 2007
add to browser selection
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study Reny, Jean-Luc; Berdagué, Philippe; Poncet, Antoine; Barazer, Isabelle; ... Fontana, Pierre 2012
add to browser selection
Aspirin "resistance" and risk of cardiovascular morbidity Fontana, Pierre; De Moerloose, Philippe; Gris, J-C.; Reny, Jean-Luc 2008
add to browser selection
Aspirin response variability assessed with the PFA-100 device Reny, Jean-Luc; Quéré, Isabelle; De Moerloose, Philippe; Fontana, Pierre 2008
add to browser selection
Assessing aspirin responsiveness using the Verify Now Aspirin assay Fontana, Pierre; Reber, Guido; De Moerloose, Philippe 2008
add to browser selection
Can the phenotype of inherited fibrinogen disorders be predicted? Casini, Alessandro; De Moerloose, Philippe 2016
add to browser selection
Chapter 12 Blood coagulation and fibrinolysis: mechanisms of thrombosis De Moerloose, Philippe; Boehlen, Françoise 2008
add to browser selection
Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendency Zawilska, Krystyna; Undas, Anetta; Fish, R. J.; Molendowicz-Portala, Lucyna; ... Neerman Arbez, Marguerite 2010
add to browser selection
Clinical Features and Management of Congenital Fibrinogen Deficiencies Casini, Alessandro; De Moerloose, Philippe; Neerman Arbez, Marguerite 2016
add to browser selection
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study Fontana, Pierre; Berdague, P.; Castelli, C.; Nolli, S.; ... Reny, Jean-Luc 2010
add to browser selection
Combined factor V - factor VIII deficiency (F5F8D): compound heterozygosity for two novel truncating mutations in LMAN1 in a consanguineous patient Farah, R. A.; De Moerloose, Philippe; Bouchardy, Isabelle; Morris, Michael Andréw; ... Neerman Arbez, Marguerite 2006
add to browser selection
Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems Moll, Solange; De Moerloose, Philippe; Reber, G; Schifferli, J; Leski, Michel 1990
add to browser selection
Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion Vu, Dung; Bolton-Maggs, P. H.; Parr, J. R.; Morris, Michael Andréw; ... Neerman Arbez, Marguerite 2003
add to browser selection
Congenital Disorders of Fibrinogen: Clinical Presentations, Diagnosis and Management Casini, Alessandro; De Moerloose, Philippe 2016
add to browser selection
Congenital fibrinogen disorders De Moerloose, Philippe; Neerman Arbez, Marguerite 2009
add to browser selection
Congenital fibrinogen disorders: an update De Moerloose, Philippe; Casini, Alessandro; Neerman Arbez, Marguerite 2013
add to browser selection
Could Factor XIII be a solution for the management of surgical bleeding? Casini, Alessandro; De Moerloose, Philippe 2013
add to browser selection
D-Dimer for venous thromboembolism diagnosis: 20 years later Righini, M.; Perrier, Arnaud; De Moerloose, Philippe; Bounameaux, Henri 2008
add to browser selection
Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency Nyfeler, Beat; Kamiya, Yukiko; Boehlen, Françoise; Yamamoto, Kazuo; ... Neerman Arbez, Marguerite 2008
add to browser selection
Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH Casini, Alessandro; Undas, A; Palla, R; Thachil, J; De Moerloose, Philippe 2018
add to browser selection
Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand? Marchetti, Tess; Cohen, Marie-Benoîte; Gris, Jean-Christophe; De Moerloose, Philippe 2013
add to browser selection
Diagnosis of mild bleeding disorders De Moerloose, Philippe; Levrat, Emmanuel; Fontana, Pierre; Boehlen, Françoise 2009
add to browser selection
Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management Casini, Alessandro; Neerman Arbez, Marguerite; Ariëns, R A; De Moerloose, Philippe 2015
add to browser selection
Endothelial cell activation by immunoglobulins from patients with immune thrombocytopenic purpura or with antiphospholipid syndrome Geindre, Sylvie Françoise; Boehlen, Françoise; Favier, Remi; Wahl, Denis; ... De Moerloose, Philippe 2008
add to browser selection
European curriculum for thrombosis and haemostasis Astermark, J.; Negrier, C.; Hermans, C.; Holme, P. A.; ... Ludlam, C. A. 2009
add to browser selection
Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? Fontana, Pierre; Bonvini, Robert; Roffi, Marco; Boehlen, Françoise; ... Reny, Jean-Luc 2010
add to browser selection
Evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism De Moerloose, Philippe; Reber, Guido; Arnout, J. 2009
add to browser selection
Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: An observational study on cord blood De Luca, Roberta; Fontana, Pierre; Poncet, Antoine; De Moerloose, Philippe; Pfister, Riccardo 2014
add to browser selection
Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in transfected cells Neerman Arbez, Marguerite; Germanos-Haddad, Myrna; Tzanidakis, Konstantinos; Vu, Dung; ... De Moerloose, Philippe 2004
add to browser selection
F-actin dampens NLRP3 inflammasome activity via Flightless-I and LRRFIP2 Burger, Danielle; Fickentscher, Céline; De Moerloose, Philippe; Brandt, Karim 2016
add to browser selection
Factor concentrates for rare congenital coagulation disorders: where are we now? Casini, Alessandro; De Moerloose, Philippe 2016
add to browser selection
FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations Casini, Alessandro; Lukowski, Samuel; Quintard, V Louvain; Crutu, A; ... Neerman Arbez, Marguerite 2014
add to browser selection
Fibrinogen and the risk of thrombosis De Moerloose, Philippe; Boehlen, Françoise; Neerman Arbez, Marguerite 2010
add to browser selection
Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A. Casini, Alessandro; De Maistre, Emmanuel; Casini-Stuppi, Virginie; Fontana, Pierre; ... De Moerloose, Philippe 2014
add to browser selection
Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function Undas, Anetta; Zdziarska, Joanna; Iwaniec, Teresa; Stepien, Ewa; ... Neerman Arbez, Marguerite 2009
add to browser selection
Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization Amri, Y; Jouini, H; Becheur, M; Dabboubi, R; ... Toumi, N E H 2017
<< previous | 1 | 2 | 3 |